{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T10:32:06Z","timestamp":1755599526569},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,28]]},"DOI":"10.7759\/cureus.29689","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T13:37:19Z","timestamp":1664372239000},"source":"Crossref","is-referenced-by-count":1,"title":["Clinically Suspected Exercise-Induced Myocarditis in a Patient With Vascular Ehlers-Danlos Syndrome"],"prefix":"10.7759","author":[{"given":"Rishi","family":"Kalia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merly","family":"Cubelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Musih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesal","family":"Popat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12319926","article-title":"Ehlers-Danlos syndrome type IV: a genetic disorder in many guises","volume":"105","author":"Byers PH","year":"1995","unstructured":"Byers PH. Ehlers-Danlos syndrome type IV: a genetic disorder in many guises. J Invest Dermatol. 1995, 105:311-3. 10.1111\/1523-1747.ep12319926","journal-title":"J Invest Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60960-9","article-title":"Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial","volume":"376","author":"Ong KT","year":"2010","unstructured":"Ong KT, Perdu J, De Backer J, et al.. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet. 2010, 376:1476-84. 10.1016\/S0140-6736(10)60960-9","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200003093421001","article-title":"Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type","volume":"342","author":"Pepin M","year":"2000","unstructured":"Pepin M, Schwarze U, Superti-Furga A, Byers PH. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med. 2000, 342:673-80. 10.1056\/NEJM200003093421001","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","volume":"18","author":"Tsch\u00f6pe C","year":"2021","unstructured":"Tsch\u00f6pe C, Ammirati E, Bozkurt B, et al.. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021, 18:169-93. 10.1038\/s41569-020-00435-x","journal-title":"Nat Rev Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.01.058","article-title":"Vascular Ehlers-Danlos syndrome: long-term observational study","volume":"73","author":"Frank M","year":"2019","unstructured":"Frank M, Adham S, Seigle S, et al.. Vascular Ehlers-Danlos syndrome: long-term observational study. J Am Coll Cardiol. 2019, 73:1948-57. 10.1016\/j.jacc.2019.01.058","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.769489","article-title":"Predictors of outcome in patients with suspected myocarditis","volume":"118","author":"Kindermann I","year":"2008","unstructured":"Kindermann I, Kindermann M, Kandolf R, et al.. Predictors of outcome in patients with suspected myocarditis. Circulation. 2008, 118:639-48. 10.1161\/CIRCULATIONAHA.108.769489","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(97)01034-5","article-title":"Acute hemodynamic effects of metoprolol +\/- nitroglycerin in patients with biopsy-proven lymphocytic myocarditis","volume":"81","author":"Popovi\u0107 Z","year":"1998","unstructured":"Popovi\u0107 Z, Miri\u0107 M, Vasiljevi\u0107 J, Sagi\u0107 D, Boji\u0107 M, Popovi\u0107 AD. Acute hemodynamic effects of metoprolol +\/- nitroglycerin in patients with biopsy-proven lymphocytic myocarditis. Am J Cardiol. 1998, 81:801-4. 10.1016\/s0002-9149(97)01034-5","journal-title":"Am J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/112809-clinically-suspected-exercise-induced-myocarditis-in-a-patient-with-vascular-ehlers-danlos-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:15Z","timestamp":1707508095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/112809-clinically-suspected-exercise-induced-myocarditis-in-a-patient-with-vascular-ehlers-danlos-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.29689","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,28]]}}}